ConductScience.org, home

Paper5778426

Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.

Charytan C and 1 other. N Engl J Med, 1969. Cited by 131 papers, by iCite.

Cite this record

ConductScience Library. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. Papers, record 5778426. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5778426

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.
PubMed
Journal
N Engl J Med
PubMed
Year
1969
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
131
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Charytan CC
2Purtilo DD

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acute Kidney InjuryMajor topic
AminocaproatesMajor topic
Kidney GlomerulusMajor topic
ThrombosisMajor topic
Aged
Biopsy
Hematuria
Humans
Male
Prostatic Neoplasms

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.

PMIDTitleJournalYearIn PapersSource
39954183Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: significance of guidelines developed for each underlying disease.Int J Hematol2025https://conductscience.org/library/papers/39954183PubMed
39792236Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities.Int J Hematol2025https://conductscience.org/library/papers/39792236PubMed
39434960Distinguishing hyperfibrinolysis from enhanced-fibrinolytic-type disseminated intravascular coagulation.Res Pract Thromb Haemost2024https://conductscience.org/library/papers/39434960PubMed
38732176How We Interpret Thrombosis with Thrombocytopenia Syndrome?Int J Mol Sci2024https://conductscience.org/library/papers/38732176PubMed
35163216Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.Int J Mol Sci2022https://conductscience.org/library/papers/35163216PubMed
33175341Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.Int J Hematol2021https://conductscience.org/library/papers/33175341PubMed
32639181Consideration of Tranexamic Acid Administration to COVID-19 Patients.Physiol Rev2020https://conductscience.org/library/papers/32639181PubMed
31416465Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.Crit Care2019https://conductscience.org/library/papers/31416465PubMed
28420841Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.Intern Med2017https://conductscience.org/library/papers/28420841PubMed
26071040Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.BMC Pregnancy Childbirth2015https://conductscience.org/library/papers/26071040PubMed
25520834Classifying types of disseminated intravascular coagulation: clinical and animal models.J Intensive Care2014https://conductscience.org/library/papers/25520834PubMed
20039075Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.J Anesth2010https://conductscience.org/library/papers/20039075PubMed
18386187Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.Neurocrit Care2008https://conductscience.org/library/papers/18386187PubMed
14993107The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.Br J Pharmacol2004https://conductscience.org/library/papers/14993107PubMed
9152974Acute promyelocytic leukaemia in the all trans retinoic acid era.Med Oncol1996https://conductscience.org/library/papers/9152974PubMed
8703716Protracted, gross hematuria in sickle cell trait: response to multiple doses of 1-desamino-8-D-arginine vasopressin.Pediatr Nephrol1996https://conductscience.org/library/papers/8703716PubMed
8647936Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.J Clin Invest1996https://conductscience.org/library/papers/8647936PubMed
7580358Antifibrinolytic therapy in cardiac surgery.Tex Heart Inst J1995https://conductscience.org/library/papers/7580358PubMed
7435291Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7435291PubMed
7427206Acute renal failure and myopathy after treatment with aminocaproic acid.Br Med J1980https://conductscience.org/library/papers/7427206PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5778426

GET https://conductscience.org/api/papers/v1/5778426/cited_by?page=2